This page is kept for reference and is not offered to search engines.
In other countries
The same active substances on other registers, the same brand first.
- SylvantCanada · 400 MG / VIAL · Powder For Solution · Recordati Rare Diseases Canada INCSame brand
- SylvantCanada · 100 MG / VIAL · Powder For Solution · Recordati Rare Diseases Canada INCSame brand
- Sylvant 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100 mg · polvo para concentrado para solución para perfusión · Recordati Netherlands B.V.Same brand
- SylvantEuropean Union · Recordati Netherlands B.V.Same brand
- SylvantCroatiaSame brand
- SylvantItaly · Polvere per concentrato per soluzione per infusione · Recordati Netherlands B.V.Same brand
- Sylvant 100 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · EUSA Pharma (Netherlands) B.V.Same brand
- Sylvant 400 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · EUSA Pharma (Netherlands) B.V.Same brand
- SylvantNew Zealand · Inj 400 mg vialSame brand
- SylvantNew Zealand · Inj 100 mg vialSame brand
- SYLVANT 100 mgRomania · 100 mg · pulb. pt. conc. pt. sol. perf. · Eusa Pharma ( Netherlands) BVSame brand
- SYLVANT 100mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · JanssenSame brand
- SYLVANT 400 mgRomania · 400 mg · pulb. pt. conc. pt. sol. perf. · Eusa Pharma ( Netherlands) BVSame brand
- Sylvant Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for solution · Pharm-D Singapore Private LimitedSame brand
- Sylvant Powder for Concentrate for Solution for Infusion 400MG/VialSingapore · 400mg/vial · injection, powder, lyophilized, for solution · Pharm-D Singapore Private LimitedSame brand
- SylvantUnited States · 100MG, 400MG · injectable · Recordati Rare Diseases, INC.Same brand
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Siltuximab
- Register
- Brazil (Anvisa)
- Status
- Cancelled
- Status in the register
- Inativo
- Authorised
- 14 Jun 2021
- Registration
- 151890004
- Marketing authorisation holder
- Collect Importação e Comércio Ltda
- Procedure
- Registered